Health
Nurses at Ramsay Health Care hospitals in New South Wales go on 24-hour strike
Hundreds of nurses and midwives at Ramsay Health Care’s 17 hospitals in Australia’s New South Wales will stage a 24-hour strike on Tuesday demanding higher
The FDA is considering a Wegovy shortage
More than 200,000 prescriptions for copies of Novo Nordisk’s weight-loss drug Wegovy are purchased by patients in the US each month, an industry group said
US FDA approves BridgeBio drug for rare heart disease
The US FDA approved BridgeBio’s drug for a rare and deadly heart disease, transthyretin amyloid cardiomyopathy, making it the first new treatment in a market
US Centres for Disease Control and Prevention confirms H5N1 avian flu in a child in California
The US Centres for Disease Control and Prevention on Friday confirmed the country’s first case of H5N1 bird flu infection in a child who had
Canada confirms its first case of clade I mpox
The Public Health Agency of Canada on Friday confirmed the first case of clade I mpox in Canada in a Manitoba man. The Public Health
Trump’s pick for FDA is surgeon and author Martin Makary
US President-elect Donald Trump has nominated surgeon and author Martin Makary to head the Food and Drug Administration, the world’s most powerful drug regulator with
Novartis raises its sales forecast to 2028
Novartis raised its medium-term sales forecast to 6% annual growth until 2028, driven by momentum from launched drugs and the prospect of upcoming launches. The
Wall Street awaits Amgen’s weight-loss drug data
Upcoming data from a mid-stage study of Amgen’s experimental weight-loss drug MariTide will shed light on how well it could measure up against popular drugs
Neuralink receives Canadian approval for brain chip trial
Elon Musk’s Neuralink said it received approval to launch its first clinical trial in Canada for a device designed to give paralysed people the ability
Pfizer appoints Chris Boshoff as R&D director
Pfizer named company veteran Chris Boshoff, who led the drugmaker’s cancer research and marketing for more than a year, as its head of research and